Despite the decline in recent weeks, Beyond Meat stock remains dearly valued at a price-to-sales ratio of close to 40 based on this year’s expected revenue. This valuation puts it in a league with start-up biotech stocks and some high-priced cloud stocks. Media coverage continues to be overwhelmingly positive for Beyond Meat and its rival Impossible Foods, indicating that the outstanding growth they’ve seen lately should continue at least for the immediate future, but the valuation concerns aren’t going away anytime soon.

Source: Why Beyond Meat Shares Were Slumping Today – Nasdaq.com

By Grégory Maubon

Leading Innovation ++ on the Field ++ with a Purpose => I used AI in cultivated meat industry to optimize bioreactor design and to dramatically improve the efficiency and quality of production. I developed high quality 3D imagery process in a biotechnological startup to disrupt the drug discovery methods.

Leave a Reply

Your email address will not be published. Required fields are marked *